References
- Adams PD. Healing and hurting: molecular mechanisms, functions, and pathologies of cellular senescence. Mol Cell 2009; 36: 2-14. https://doi.org/10.1016/j.molcel.2009.09.021
- Arendt T, Mosch B, Morawski M. Neuronal aneuploidy in health and disease: a cytomic approach to understand the molecular individuality of neurons. Int J Mol Sci 2009; 10: 1609-1627. https://doi.org/10.3390/ijms10041609
- Bolden J, Shi W, Jankowski K, Kan C, Cluse L, Martin B, MacKenzie K, Smyth G, Johnstone R. HDAC inhibitors induce tumor-cell-selective pro-apoptotic transcriptional responses. Cell Death Dis 2013; 4: e519. https://doi.org/10.1038/cddis.2013.9
- Campisi J. Aging, cellular senescence, and cancer. Annu Rev Physiol 2013; 75: 685-705. https://doi.org/10.1146/annurev-physiol-030212-183653
- Campisi J, di Fagagna FdA. Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol 2007; 8: 729-740. https://doi.org/10.1038/nrm2233
- Chen J-H, Hales CN, Ozanne SE. DNA damage, cellular senescence and organismal ageing: causal or correlative? Nucleic Acids Res 2007; 35: 7417-7428. https://doi.org/10.1093/nar/gkm681
- Cohen L, Powers B, Amin S, Desai D. Treatment of canine haemangiosarcoma with suberoylanilide hydroxamic acid, a histone deacetylase inhibitor. Vet Comp Oncol 2004; 2: 243-248. https://doi.org/10.1111/j.1476-5810.2004.00057.x
- Di Bernardo G, Squillaro T, Dell'Aversana C, Miceli M, Cipollaro M, Cascino A, Altucci L, Galderisi U. Histone deacetylase inhibitors promote apoptosis and senescence in human mesenchymal stem cells. Stem Cells Dev 2009; 18: 573-582. https://doi.org/10.1089/scd.2008.0172
- Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, Medrano EE, Linskens M, Rubelj I, Pereira-Smith O. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci U S A 1995; 92:9363-9367. https://doi.org/10.1073/pnas.92.20.9363
- Duvic M, Talpur R, Ni X, Zhang C, Hazarika P, Kelly C, Chiao JH, Reilly JF, Ricker JL, Richon VM. Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL). Blood 2007; 109: 31-39. https://doi.org/10.1182/blood-2006-06-025999
- Falkenberg KJ, Johnstone RW. Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders. Nat Rev Drug Discov 2014;
- Ferbeyre G, De Stanchina E, Lin AW, Querido E, McCurrach ME, Hannon GJ, Lowe SW. Oncogenic ras and p53 cooperate to induce cellular senescence. Mol Cell Biol 2002;22: 3497-3508. https://doi.org/10.1128/MCB.22.10.3497-3508.2002
- Ferreira R, Naguibneva I, Pritchard LL, Ait-Si-Ali S, Harel-Bellan A. The Rb/chromatin connection and epigenetic control: opinion. Oncogene 2001; 20:
- Hayflick L, Moorhead PS. The serial cultivation of human diploid cell strains. Exp Cell Res 1961; 25: 585-621. https://doi.org/10.1016/0014-4827(61)90192-6
- Herbig U, Ferreira M, Condel L, Carey D, Sedivy JM. Cellular senescence in aging primates. Science 2006; 311: 1257-1257. https://doi.org/10.1126/science.1122446
- Jackson SP, Bartek J. The DNA-damage response in human biology and disease. Nature 2009; 461: 1071-1078. https://doi.org/10.1038/nature08467
- Ju Z, Choudhury AR, Rudolph KL. A dual role of p21 in stem cell aging. Ann N Y Acad Sci 2007; 1100: 333-344. https://doi.org/10.1196/annals.1395.036
- Kaeberlein M, Creevy KE, Promislow DE. The dog aging project: translational geroscience in companion animals. Mamm Genome 2016; 1-10.
- Kalousek I, Brodska B, Otevrelova P, Roselova P. BimEL dependent apoptosis induced in peripheral blood lymphocytes with n butyric acid is moderated by variation in expression of c myc and p21 (WAF1). Cell Biochem Funct 2008; 26:509-521. https://doi.org/10.1002/cbf.1474
- Kim MJ, Oh HJ, Kim GA, Suh HN, Jo YK, Choi YB, Kim DH, Han HJ, Lee BC. Altering histone acetylation status in donor cells with suberoylanilide hydroxamic acid does not affect dog cloning efficiency. Theriogenology 2015;
- Kisseberth WC, Murahari S, London CA, Kulp SK, Chen C-S. Evaluation of the effects of histone deacetylase inhibitors on cells from canine cancer cell lines. Am J Vet Res 2008; 69: 938-945. https://doi.org/10.2460/ajvr.69.7.938
- Kurihara Y, Suzuki T, Sakaue M, Murayama O, Miyazaki Y, Onuki A, Aoki T, Saito M, Fujii Y, Hisasue M. Valproic acid, a histone deacetylase inhibitor, decreases proliferation of and induces specific neurogenic differentiation of canine adipose tissue-derived stem cells. J Vet Med Sci 2014; 76:15. https://doi.org/10.1292/jvms.13-0219
- Lee BC, Kim MK, Jang G, Oh HJ, Yuda F, Kim HJ, Shamim MH, Kim JJ, Kang SK, Schatten G, Hwang WS. Dogs cloned from adult somatic cells. Nature 2005; 436: 641. https://doi.org/10.1038/436641a
- Machida S, Booth FW. Increased nuclear proteins in muscle satellite cells in aged animals as compared to young growing animals. Exp Gerontol 2004; 39: 1521-1525. https://doi.org/10.1016/j.exger.2004.08.009
- McKevitt TP, Nasir L, Devlin P, Argyle DJ. Telomere lengths in dogs decrease with increasing donor age. J Nutr 2002; 132: 1604S-1606S. https://doi.org/10.1093/jn/132.6.1604S
- Munro J, Barr NI, Ireland H, Morrison V, Parkinson EK. Histone deacetylase inhibitors induce a senescence-like state in human cells by a p16-dependent mechanism that is independent of a mitotic clock. Exp Cell Res 2004; 295: 525-538. https://doi.org/10.1016/j.yexcr.2004.01.017
- Paoloni M, Khanna C. Translation of new cancer treatments from pet dogs to humans. Nat Rev Cancer 2008; 8: 147-156. https://doi.org/10.1038/nrc2273
- Peleg S, Sananbenesi F, Zovoilis A, Burkhardt S, Bahari-Javan S, Agis-Balboa RC, Cota P, Wittnam JL, Gogol-Doering A, Opitz L. Altered histone acetylation is associated with age-dependent memory impairment in mice. Science 2010; 328: 753-756. https://doi.org/10.1126/science.1186088
- Pinho SS, Carvalho S, Cabral J, Reis CA, Gartner F. Canine tumors: a spontaneous animal model of human carcinogenesis. Transl Res 2012; 159: 165-172. https://doi.org/10.1016/j.trsl.2011.11.005
- Place RF, Noonan EJ, Giardina C. HDACs and the senescent phenotype of WI-38 cells. BMC Cell Biol 2005; 6: 37. https://doi.org/10.1186/1471-2121-6-37
- Pospelova TV, Chitikova ZV, Pospelov VA. An integrated approach for monitoring cell senescence. Methods Mol Biol 2013; 383-408.
- Purrucker JC, Fricke A, Ong MF, Rube C, Rube CE, Mahlknecht U. HDAC inhibition radiosensitizes human normal tissue cells and reduces DNA Double-Strand Break repair capacity. Oncol Rep 2010; 23: 263-269.
- Rao MS, Hattiangady B, Shetty AK. The window and mechanisms of major age related decline in the production of new neurons within the dentate gyrus of the hippocampus. Aging cell 2006; 5: 545-558. https://doi.org/10.1111/j.1474-9726.2006.00243.x
- Ressler S, Bartkova J, Niederegger H, Bartek J, Scharffetter Kochanek K, Jansen Durr P, Wlaschek M. p16INK4A is a robust in vivo biomarker of cellular aging in human skin. Aging Cell 2006; 5: 379-389. https://doi.org/10.1111/j.1474-9726.2006.00231.x
- Sardiu ME, Smith KT, Groppe BD, Gilmore JM, Saraf A, Egidy R, Peak A, Seidel CW, Florens L, Workman JL. Suberoylanilide Hydroxamic Acid (SAHA)-Induced Dynamics of a Human Histone Deacetylase Protein Interaction Network. Mol Cell Proteomics 2014; 13: 3114-3125. https://doi.org/10.1074/mcp.M113.037127
- Sikora E, Arendt T, Bennett M, Narita M. Impact of cellular senescence signature on ageing research. Ageing Res Rev 2011; 10: 146-152. https://doi.org/10.1016/j.arr.2010.10.002
- Stilling RM, Fischer A. The role of histone acetylation in age-associated memory impairment and Alzheimer's disease. Neurobiol Learn Mem 2011; 96: 19-26. https://doi.org/10.1016/j.nlm.2011.04.002
- Wittenburg LA, Bisson L, Rose BJ, Korch C, Thamm DH. The histone deacetylase inhibitor valproic acid sensitizes human and canine osteosarcoma to doxorubicin. Cancer Chemother Pharmacol 2011; 67: 83-92. https://doi.org/10.1007/s00280-010-1287-z
- Yeo W, Chung HC, Chan SL, Wang LZ, Lim R, Picus J, Boyer M, Mo FK, Koh J, Rha SY. Epigenetic therapy using belinostat for patients with unresectable hepatocellular carcinoma: a multicenter phase I/II study with biomarker and pharmacokinetic analysis of tumors from patients in the Mayo Phase II Consortium and the Cancer Therapeutics Research Group. J Clin Oncol 2012; 30: 3361-3367. https://doi.org/10.1200/JCO.2011.41.2395
- Yoo DY, Kim W, Kim IH, Nam SM, Chung JY, Choi JH, Yoon YS, Won M-H, Hwang IK. Combination effects of sodium butyrate and pyridoxine treatment on cell proliferation and neuroblast differentiation in the dentate gyrus of D-galactose-induced aging model mice. Neurochem Res 2012; 37: 223-231. https://doi.org/10.1007/s11064-011-0597-9